SEC Form 4 · accession 0000874716-26-000125
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Emerson
Officer — EVP, CFO and Treasurer
Period of report
Aug 20, 2026
Accepted (ET)
Aug 24, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 20, 2026 | M | 265 | $178.26 | A | 4,507 | D | |
| Common Stock | Aug 20, 2026 | F | 86 | $0.00 | D | 4,421 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right-to-buy)F3,F2 | $178.26 | Aug 20, 2026 | M | 265 | D | — | Feb 13, 2028 | Common Stock | 265 | 925 | D |
Explanation of responses
- F1Includes a total of 20 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2026 and June 30, 2026.
- F2Grant of option to buy 1,190 shares of Issuer common stock that became exercisable in one installment on February 14, 2023.
- F3Not applicable